Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|January 12, 2010
Embryonic and adult stem cell therapyAnne C Brignier, Alan M GewirtzBlood|May 21, 2010
c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell developmentYuji Nakata, Anne C Brignier, Shenghao Jin, et al.The Journal of Clinical Investigation|December 7, 2007
On future's doorstep: RNA interference and the pharmacopeia of tomorrowAlan M GewirtzBlood Cells, Molecules & Diseases|January 12, 2007
RNA targeted therapeutics for hematologic malignanciesAlan M GewirtzBlood|November 3, 2009
A prototype nonpeptidyl, hydrazone class, thrombopoietin receptor agonist, SB-559457, is toxic to primary human myeloid leukemia cellsAnna Kalota, Alan M GewirtzNature Reviews. Drug Discovery|July 18, 2002
Nucleic-acid therapeutics: basic principles and recent applicationsJoanna B Opalinska, Alan M GewirtzScience'S STKE : Signal Transduction Knowledge Environment|October 30, 2003
Therapeutic potential of antisense nucleic acid moleculesJoanna B Opalinska, Alan M GewirtzExpert Opinion on Biological Therapy|December 2, 2005
RNA interference for treating haematological malignanciesElizabeth O Hexner, Alan M GewirtzThe Journal of Biological Chemistry|November 24, 2011
The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemiaHuiwu Zhao, Shenghao Jin, Alan M GewirtzCancer Biology & Therapy|January 17, 2004
Progress in the development of nucleic acid therapeutics for cancerAnna Kalota, Susan E Shetzline, Alan M GewirtzPageof 5